U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07716969) titled 'TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis' on July 16.
Brief Summary: This study examines whether an early-detection program for psychosis can shorten the time patients remain untreated after the first appearance of psychotic symptoms, and whether such a reduction improves later functioning for people with first-episode schizophrenia.
Psychosis involves symptoms such as hallucinations and delusions. When these symptoms are recognized and treatment begins, most patients improve. However, many individuals live with psychotic symptoms for months-or even longer-before receiving care. This per...